Bitcoin
76543.52
+638.2
+0.83%
Crude Oil
101.21
-0.65
-0.64%
Gold
4382.9
+80.7
+1.84%
Copper
6.61
+0.18
+2.67%
Silver
65.79
+2.44
+3.72%
Dow Jones
51461.9
-631.21
-1.23%
SP500
7642.29
+90.48
+1.18%
NASDAQ
25978.42
-3.15
-0.01%

CheckMan Stock Market Overview

Trending Stocks

Name and Ticker
Last
% Change
% Change and Signal
Volume
Signal
5.85
+98.00%
Top Gainers
145,658
Top Gainers
2.1
+96.67%
Top Gainers
1,810,684
Top Gainers
2.66
+91.24%
Top Gainers
45,243,485
Top Gainers
1.28
+53.81%
Top Gainers
2,129,685
Top Gainers
5.16
+50.00%
Top Gainers
465,685
Top Gainers
8.1
+47.41%
Top Gainers
128,622
Top Gainers
2.84
+36.97%
Top Gainers
323,019
Top Gainers
1.7803
+36.53%
Top Gainers
972,111
Top Gainers
1.32
+29.02%
Top Gainers
677,960
Top Gainers
3.86
+29.02%
Top Gainers
118,875
Top Gainers

Red List

Name and Ticker
Last
% Change
% Change and Signal
Volume
Signal
2.73
-144.69%
Top Loosers
941,580
Top Loosers
5.5
-94.00%
Top Loosers
604,695
Top Loosers
82700
-81.02%
Top Loosers
763,022
Top Loosers
1.735
-80.98%
Top Loosers
522,208
Top Loosers
6.51
-58.22%
Top Loosers
1,410,385
Top Loosers
20.96
-53.96%
Top Loosers
229,459
Top Loosers
28.56
-49.75%
Top Loosers
108,249
Top Loosers
4.37
-34.32%
Top Loosers
2,959,844
Top Loosers
5.13
-24.56%
Top Loosers
117,632
Top Loosers
1.27
-24.41%
Top Loosers
522,877
Top Loosers

In Today's Headlines

Meta's AI chips and Meta One strengthen Bank of America's outlook
03:38
18 Sep 2026
Meta's AI chips and Meta One strengthen Bank of America's outlook

Meta Platforms Inc (NASDAQ:META, XETRA:FB2A, SIX:FB) custom AI chip plans and global launch of Meta One reinforced Bank of America's "buy" rating, with the broker highlighting potential savings and subscription revenue. Citing Bloomberg, analysts noted Meta plans to deploy MTIA 450, or Arke, in the first half of 2027, followed by MTIA 500, or Astrid, late that year.

Salesforce Stock Looks Enticing After Dreamforce 2026
03:37
18 Sep 2026
Salesforce Stock Looks Enticing After Dreamforce 2026

Salesforce, Inc. remains a Buy as AI tailwinds drive robust growth and strong demand despite market fears of a 'SaaSpocalypse.' Q2 revenue grew 11% YoY to $11.3B, Agentforce ARR soared 240%+, and constant currency cRPO growth accelerated to 14%, signaling strengthening enterprise demand. AIforce and Koa launches at Dreamforce reinforce Salesforce's strategic AI leadership and support management's $63B+ revenue target by 2030.

Short-Term Bond ETFs to Gain as Fed Hikes Interest Rates
03:31
18 Sep 2026
Short-Term Bond ETFs to Gain as Fed Hikes Interest Rates

ETFs like SHY could benefit as the Fed hikes rates, with short-term debt offering rising yields and limited duration risk.

Gasoline ETF (UGA) Touches New 52-Week High
03:31
18 Sep 2026
Gasoline ETF (UGA) Touches New 52-Week High

UGA hits a 52-week high after surging 141.6%, likely fueled by Middle East tensions, refinery outages and inventory drawdowns.

HIMS Investors with Losses in Excess of $100K Have Opportunity to Lead Hims & Hers Health, Inc. Securities Fraud Lawsuit
03:31
18 Sep 2026
HIMS Investors with Losses in Excess of $100K Have Opportunity to Lead Hims & Hers Health, Inc. Securities Fraud Lawsuit

NEW YORK, Sept. 17, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Hims & Hers Health, Inc. (NYSE: HIMS) between August 4, 2025 and July 29, 2026, both dates inclusive (the "Class Period"), of the important November 2, 2026 lead plaintiff deadline.

Kaplan Fox Reminds Investors: Microvast Holdings, Inc. (MVST) Securities Class Action Deadline is September 21, 2026
03:30
18 Sep 2026
Kaplan Fox Reminds Investors: Microvast Holdings, Inc. (MVST) Securities Class Action Deadline is September 21, 2026

New York, New York--(Newsfile Corp. - September 17, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Microvast Holdings, Inc. ("Microvast" or the "Company") (NASDAQ: MVST) on behalf of investors that purchased or otherwise acquired Microvast securities between April 1, 2025 and March 16, 2026 (the "Class Period"). CLICK HERE TO JOIN THE CASE If you are an investor in Microvast and have suffered losses, you may CLICK HERE to contact us.

SEPTEMBER 28, 2026 BE INVESTOR DEADLINE: Bloom Energy Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - RGRD Law
03:30
18 Sep 2026
SEPTEMBER 28, 2026 BE INVESTOR DEADLINE: Bloom Energy Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - RGRD Law

SAN DIEGO, Sept. 17, 2026 (GLOBE NEWSWIRE) -- The law firm of  Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Bloom Energy Corporation (NYSE: BE) securities between February 27, 2025 and July 8, 2026, both dates inclusive (the “Class Period”), have until Monday, September 28, 2026 to seek appointment as lead plaintiff of the Bloom Energy class action lawsuit.

Calix Agent Workforce Cloud Expands Workflows That Increase ARPU, Resolve Service Disruptions, and Improve Efficiency Across the Service Provider Business
03:30
18 Sep 2026
Calix Agent Workforce Cloud Expands Workflows That Increase ARPU, Resolve Service Disruptions, and Improve Efficiency Across the Service Provider Business

SAN JOSE, Calif.--(BUSINESS WIRE)---- $CALX #calix--Calix, Inc. (NYSE: CALX) today announced an expansion of Calix Agent Workforce Cloud™ on the AI-native Calix One™ platform, adding secure agentic workflows that help service providers operationalize AI across marketing, support, and operations. Building on the initial workflows introduced in May, the new agentic capabilities help teams collaborate seamlessly across functional boundaries—with humans in the loop—to create targeted campaigns and upsell offers, ac.

WDAY Investors Have Opportunity to Join Workday, Inc. Fraud Investigation with SBS Law
03:28
18 Sep 2026
WDAY Investors Have Opportunity to Join Workday, Inc. Fraud Investigation with SBS Law

LOS ANGELES--(BUSINESS WIRE)---- $WDAY--WDAY Investors Have Opportunity to Join Workday, Inc. Fraud Investigation with SBS Law.

Robbins LLP is Investigating Allegations that Aardvark Therapeutics, Inc. Misled Investors Regarding the Viability and Efficacy of its Lead Drug Candidate ARD-101
03:25
18 Sep 2026
Robbins LLP is Investigating Allegations that Aardvark Therapeutics, Inc. Misled Investors Regarding the Viability and Efficacy of its Lead Drug Candidate ARD-101

San Diego, California--(Newsfile Corp. - September 17, 2026) - Shareholder rights law firm Robbins LLP reminds investors that a class action was filed on behalf of all persons and entities who purchased or otherwise acquired Aardvark Therapeutics, Inc. (NASDAQ: AARD) (a) common stock pursuant to the Company's February 13, 2025 initial public offering ("IPO") and/or (b) securities between February 13, 2025 and May 14, 2026 (the "Class Period"). Aardvark is a clinical-stage biopharmaceutical company that focuses on developing small-molecule therapies designed to inhibit hunger and treat metabolic diseases such as Prader-Willi Syndrome ("PWS"), a neurodevelopmental disorder condition that presents hyperphagia, or a feeling of extreme, insatiable hunger.